AI and Value-Based Care: Machine Learning’s Potential in Reducing Healthcare Waste

By Michael Awood

October 8, 2023

According to a new study, the United States wastes $1 trillion a year on healthcare. The staggering cost of inefficiency is higher than the world’s 17th-biggest country’s GDP. Waste in healthcare affects patient care, the speed of organisations, and the cost of materials. Mistakes and wasteful spending are more likely in the healthcare system due to its complexity. This severely reduces the effectiveness of treatment.

Value-based care methods were created to deal with this issue. They promote cost-effective clinical results that lead to high-quality care at a fair price. In a data-rich environment, making decisions can become too complicated. These things cause mistakes, which make it harder to get high-value care, which wastes more time and money.

Putting this in perspective, about 80,000 people die every year in the US because of inaccurate outcomes. Even with the most up-to-date training and tools, healthcare still has problems. Maintaining awareness of the growing amount of medical info requires a lot of mental effort.

With the help of Machine Learning, both the number of mistakes and the amount of resources used could go down. Algorithms can now be used to make diagnoses instead of the human equivalent, i.e: radiologists, pathologists, and doctors. By using automations such as event reporting, you can keep patients safe. Putting together local, real-time data from institutions and social media could help with public health management and change how we predict future epidemics.

ML might be able to make personalised treatment plans for each patient based on genetic information, clinical presentation factors, and information about the patient’s past. This means that patients get more personalised care, go through fewer therapies that are unsuccessful, and have better overall outcomes.

But these changes also bring about new problems. Problems exist with both the quality of the data and our ability to understand the data that machines create. Accountability for mistakes and bad outcomes, as well as protecting patients’ privacy, are challenging.

Rising healthcare costs not only hurt countries in significant amounts, but they also threaten the foundations of value-based medicine. When it comes to keeping our healthcare system safe, ML shows itself to be a strong tool with immense potential. While there isn’t a guaranteed way to make healthcare better without also making it more efficient, ML shows promise in this area.

Reference url

Recent Posts

implantable glucose device
         

T1 Diabetes Care with an Implantable Glucose Device

🚀 Are we on the brink of a diabetes breakthrough?

A newly developed implantable glucose device from MIT could revolutionize diabetes management, providing an autonomous solution to prevent life-threatening hypoglycemic episodes. This innovative device combines continuous glucose monitoring with responsive hormone delivery, potentially transforming patient care by reducing the need for constant oversight.

Curious about how this technology could reshape diabetes outcomes and healthcare economics? Dive into the full article for a closer look!

#SyenzaNews #HealthTech #HealthEconomics #Innovation

federated learning governance
      

Federated Learning Governance in Healthcare: A Framework for Ethical and Effective Implementation

🔍 Have you considered how federated learning governance can revolutionize healthcare data collaboration?

In our latest article, we explore the critical principles of federated learning governance, emphasizing its role in managing decentralized health data while protecting patient privacy and improving research quality. Learn about the actionable strategies healthcare organizations can implement to navigate the unique challenges that come with this innovative approach.

Dive deeper into the world of federated learning in healthcare and unlock its potential for ethical and effective data use!

#SyenzaNews #AIinHealthcare #DigitalHealth

Cecolin 9 HPV vaccine
        

Cecolin 9 HPV Vaccine: A Game Changer for Cervical Cancer Prevention in China

🌍 Did you know that China has just achieved a historic milestone in the fight against cervical cancer?

The approval of the Cecolin 9 HPV vaccine, the first domestically developed 9-valent HPV vaccine, marks a transformative moment for public health, enhancing access and affordability across the nation. This development not only meets global health goals but also reshapes the landscape of cervical cancer prevention in China.

Curious to learn how this advancement is set to impact vaccination efforts and healthcare economics? Dive into the full article for deeper insights!

#SyenzaNews #globalhealth #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.